Table 2.
Sensitivity and specificity of WGS-based antimicrobial resistance predictions against the broth microdilution reference AST. Epidemiological cut-offs are applied as interpretive criteria for the reference AST
Antimicrobial | Genotyping sensitivity (95% CI) | Genotyping specificity (95% CI) |
---|---|---|
Ampicillin | 0.96 (0.88–1) | 0.93 (0.82–0.99) |
Chloramphenicol | 0.94 (0.83–0.99) | 0.94 (0.84–0.99) |
Ciprofloxacin | 0.85 (0.66–0.96) | 1 (0.95–1) |
Gentamicin | 0 (0–0.37) | 1 (0.96–1) |
Nalidixic Acid | 0.82 (0.63–0.94) | 1 (0.95–1) |
Sulfamethoxazole | 0.67 (0.54–0.78) | 0.97 (0.84–1) |
Streptomycin | 0.92 (0.83–0.97) | 0.83 (0.67–0.94) |
Sulfisoxazole | 0.62 (0.5–0.73) | 0.93 (0.77–0.99) |
Trimethoprim-Sulfamethoxazole | 0.88 (0.72–0.97) | 0.96 (0.88–0.99) |
Tetracycline | 0.95 (0.85–0.99) | 0.82 (0.68–0.92) |
Trimethoprim | 0.94 (0.79–0.99) | 0.97 (0.9–1) |
Overall | 0.83 (0.79–0.86) | 0.96 (0.94–0.97) |